BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23824408)

  • 1. Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
    Nakahigashi K; Egawa G; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2014 Mar; 94(2):239-40. PubMed ID: 23824408
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA; Werth VP; Schumacher HR
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K; Kawakami A; Hayashi T; Iwamoto N; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
    Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
    Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
    [No Abstract]   [Full Text] [Related]  

  • 7. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
    Mor A; Bingham CO; Barisoni L; Lydon E; Belmont HM
    J Rheumatol; 2005 Apr; 32(4):740-3. PubMed ID: 15801034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
    Juan A; Ribas B; Nadal C; Ros I
    J Rheumatol; 2005 Oct; 32(10):2061; author reply 2061-2. PubMed ID: 16206372
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
    Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA
    Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutropenia after the third cycle of etanercept: could it be due to immunogenicity?
    Olsen NJ; Elmagboul N
    J Clin Rheumatol; 2014 Jun; 20(4):237-8. PubMed ID: 24847756
    [No Abstract]   [Full Text] [Related]  

  • 11. Eosinophilic cellulitislike reaction to subcutaneous etanercept injection.
    Winfield H; Lain E; Horn T; Hoskyn J
    Arch Dermatol; 2006 Feb; 142(2):218-20. PubMed ID: 16490850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of pseudogout during etanercept treatment.
    Josefina M; Ana CJ; Ariel V; Silvio AA
    J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept-associated injection-site reactions.
    Murphy FT; Enzenauer RJ; Battafarano DF; David-Bajar K
    Arch Dermatol; 2000 Apr; 136(4):556-7. PubMed ID: 10768663
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis.
    Brion PH; Mittal-Henkle A; Kalunian KC
    Ann Intern Med; 1999 Oct; 131(8):634. PubMed ID: 10523238
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etanercept].
    Mühlhäuser U; Münzel F; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ; Kim HO; Kim HY; Park YM
    J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigoid nodularis possibly induced by etanercept.
    Mochizuki M; Fujine E; Tawada C; Kanoh H; Seishima M
    J Dermatol; 2013 Jul; 40(7):578-9. PubMed ID: 23594393
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
    Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute injection site reaction to intraarticular etanercept administration.
    Arnold EL; Khanna D; Paulus H; Goodman MP
    Arthritis Rheum; 2003 Jul; 48(7):2078-9. PubMed ID: 12847708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.